Lilac Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.00 M
as on 22-12-2024
- Company Age 11 Months 28 Days
- Last Filing with ROC 31 Mar 2024
About Lilac Diagnostics
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Smitha Lexman, Sabine Sivadasan, and Kesavan Devi serve as directors at the Company.
- CIN/LLPIN
U86905KL2023PTC085385
- Company No.
085385
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2023
- Date of AGM
30 Nov 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lilac Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sabine Sivadasan  | Director | 29-Dec-2023 | Current |
| Smitha Lexman | Director | 29-Dec-2023 | Current |
| Kesavan Devi | Director | 29-Dec-2023 | Current |
Financial Performance of Lilac Diagnostics.
Enhance accessibility to Lilac Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lilac Diagnostics?
Unlock access to Lilac Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Maharaja Medical Centre Pvt LtdActive 34 years 1 monthSmitha Lexman and Sabine Sivadasan are mutual person
Sabine Hospital & Research Centre Private LimitedActive 8 years 2 monthsSmitha Lexman and Sabine Sivadasan are mutual person
Hubble Infrastructure LlpActive 1 year 8 monthsSmitha Lexman and Sabine Sivadasan are mutual person
- Zapkart Technologies Private LimitedActive 5 years 23 days
Smitha Lexman and Sabine Sivadasan are mutual person
- Toscana Mercantile Private LimitedActive 6 years 9 months
Smitha Lexman and Sabine Sivadasan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lilac Diagnostics?
Unlock and access historical data on people associated with Lilac Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lilac Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lilac Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.